Pangaea Oncology SA
MAD:PANG
Pangaea Oncology SA
MAD:PANG
Price:
1.7
EUR
Market Closed
Market Cap:
€58.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pangaea Oncology SA
MAD:PANG
|
ES |
|
U
|
Under Armour Inc
F:U9RA
|
US |
|
Kruk SA
OTC:KRKKF
|
PL |
Cash Flow Statement
Cash Flow Statement
Pangaea Oncology SA
Pangaea Oncology SA
Currency: EUR
| Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(5)
|
(4)
|
(2)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
|
| Other Non-Cash Items |
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(3)
|
(3)
|
|
| Cash Taxes Paid |
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
0
|
(2)
|
(1)
|
(0)
|
0
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
0
|
(0)
|
0
|
1
|
1
|
(3)
|
(3)
|
|
| Cash from Operating Activities |
(2)
N/A
|
(4)
-119%
|
(6)
-57%
|
(5)
+27%
|
(2)
+54%
|
(1)
+35%
|
(2)
-69%
|
(3)
-8%
|
(2)
+26%
|
(2)
+4%
|
(3)
-36%
|
(3)
-3%
|
(4)
-43%
|
(3)
+7%
|
(2)
+30%
|
(3)
-11%
|
(5)
-72%
|
(5)
-2%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Other Items |
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-17%
|
(1)
-5%
|
(0)
+57%
|
(0)
+81%
|
(0)
-289%
|
(0)
+94%
|
(0)
-867%
|
(0)
+3%
|
0
N/A
|
(1)
N/A
|
(1)
-9%
|
(1)
+15%
|
(1)
-18%
|
(2)
-80%
|
(1)
+6%
|
(0)
+81%
|
(1)
-150%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
6
|
18
|
11
|
(3)
|
(2)
|
0
|
6
|
6
|
|
| Net Issuance of Debt |
6
|
5
|
3
|
4
|
0
|
(0)
|
0
|
2
|
2
|
5
|
(1)
|
(7)
|
(2)
|
(2)
|
0
|
1
|
1
|
(1)
|
|
| Other |
0
|
1
|
1
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
6
N/A
|
6
-8%
|
4
-29%
|
4
+8%
|
3
-41%
|
2
-32%
|
2
+18%
|
3
+50%
|
2
-35%
|
6
+170%
|
5
-8%
|
12
+129%
|
10
-18%
|
(5)
N/A
|
(2)
+61%
|
1
N/A
|
7
+479%
|
6
-17%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
4
N/A
|
1
-82%
|
(3)
N/A
|
(1)
+77%
|
0
N/A
|
0
-94%
|
(0)
N/A
|
0
N/A
|
(0)
N/A
|
4
N/A
|
2
-52%
|
8
+362%
|
5
-38%
|
(9)
N/A
|
(6)
+35%
|
(3)
+48%
|
2
N/A
|
0
-85%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(2)
N/A
|
(5)
-87%
|
(7)
-46%
|
(5)
+27%
|
(2)
+55%
|
(1)
+34%
|
(2)
-67%
|
(3)
-9%
|
(2)
+24%
|
(2)
+5%
|
(3)
-33%
|
(3)
-3%
|
(4)
-42%
|
(3)
+7%
|
(3)
+22%
|
(3)
-10%
|
(5)
-71%
|
(5)
-2%
|
|
Switch to:
Switch to:
See Also
Discover More
